- Home
- TPH vs OCUL Comparison
TPH vs OCUL Comparison
Compare TPH & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- OCUL
- Stock Information
- Founded
- TPH 2009
- OCUL 2006
- Country
- TPH United States
- OCUL United States
- Employees
- TPH N/A
- OCUL N/A
- Industry
- TPH Homebuilding
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- OCUL Health Care
- Exchange
- TPH Nasdaq
- OCUL Nasdaq
- Market Cap
- TPH 2.8B
- OCUL 2.3B
- IPO Year
- TPH N/A
- OCUL 2014
- Fundamental
- Price
- TPH $35.10
- OCUL $12.71
- Analyst Decision
- TPH Buy
- OCUL Strong Buy
- Analyst Count
- TPH 6
- OCUL 7
- Target Price
- TPH $42.00
- OCUL $17.83
- AVG Volume (30 Days)
- TPH 848.4K
- OCUL 2.2M
- Earning Date
- TPH 10-23-2025
- OCUL 11-13-2025
- Dividend Yield
- TPH N/A
- OCUL N/A
- EPS Growth
- TPH N/A
- OCUL N/A
- EPS
- TPH 3.96
- OCUL N/A
- Revenue
- TPH $4,041,885,000.00
- OCUL $56,664,000.00
- Revenue This Year
- TPH N/A
- OCUL N/A
- Revenue Next Year
- TPH $1.33
- OCUL $18.87
- P/E Ratio
- TPH $8.84
- OCUL N/A
- Revenue Growth
- TPH N/A
- OCUL N/A
- 52 Week Low
- TPH $27.90
- OCUL $5.79
- 52 Week High
- TPH $46.91
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- TPH 50.67
- OCUL 53.64
- Support Level
- TPH $34.49
- OCUL $12.27
- Resistance Level
- TPH $36.40
- OCUL $13.07
- Average True Range (ATR)
- TPH 0.93
- OCUL 0.64
- MACD
- TPH -0.20
- OCUL -0.08
- Stochastic Oscillator
- TPH 20.13
- OCUL 37.70
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.